AdvaMed Tells US FDA Which Guidelines Need To Be Finalized First
This article was originally published in Clinica
US medtech trade group AdvaMed is calling on the Food and Drug Administration to prioritize completing five of the 12 final guidelines that the agency said it intends to complete in fiscal year 2016, including guidelines on medical device accessories and unique device identification (UDI) direct marking.
You may also be interested in...
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.